Stabilization notice

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES Carnegie Investment Bank AB (publ) (”Carnegie”) notifies that stabilization measures have been undertaken in Q-linea AB (publ) (”Q-linea” or the “Company”) shares traded on Nasdaq Stockholm.

Trading in Q-linea’s share commences tomorrow on Nasdaq Stockholm

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS APPLY. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.

Q-linea publishes prospectus for Initial Public Offering on Nasdaq

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.

Q-linea intends to list its shares on Nasdaq Stockholm

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.

Notice to extraordinary general meeting in Q-linea AB

In Swedish only. Aktieägarna i Q-linea AB (publ), org.nr. 556729-0217 (”Bolaget”), kallas härmed till extra bolagsstämma måndagen den 12 november 2018 kl. 09.30 i Advokatfirman Lindahls lokaler, Vaksalagatan 10, Uppsala.

Q-linea AB acquires Umbrella Science

UPPSALA, Sweden, June 30th, 2018 - Q-linea AB, a diagnostic company focused on developing and delivering solutions to accurately and rapidly diagnose infectious diseases, announced that the company has acquired Umbrella Science AB in an asset deal. The total purchase price is SEK 12.8 million.

Q-linea AB secures SEK 151.5 million in funding

UPPSALA, Sweden, June 18, 2018 - Q-linea AB, a diagnostic company focused on developing and delivering solutions to accurately and rapidly diagnose infectious diseases, announced today that the company secured SEK 151.5 million from existing shareholders and a group of Swedish investors. Lead investors were Investment AB Öresund and the Fourth AP fund.